Gabelli Funds LLC Reduces Stock Position in Avantor, Inc. $AVTR

Gabelli Funds LLC lessened its holdings in Avantor, Inc. (NYSE:AVTR) by 51.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 181,000 shares of the company’s stock after selling 189,237 shares during the quarter. Gabelli Funds LLC’s holdings in Avantor were worth $2,074,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. EverSource Wealth Advisors LLC grew its holdings in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor during the second quarter worth about $32,000. Private Trust Co. NA grew its holdings in shares of Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after purchasing an additional 875 shares during the last quarter. Osaic Holdings Inc. grew its holdings in shares of Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Avantor by 28.1% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock worth $49,000 after buying an additional 905 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor News Summary

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Zacks Research lifted its FY2027 EPS estimate for Avantor to $0.84 from $0.82 and increased FY2028 EPS to $0.91 from $0.84, suggesting improved longer-term earnings potential.
• Positive Sentiment: The firm also raised Q2 2027 EPS to $0.19 from $0.16 and Q4 2027 EPS to $0.23 from $0.22, reinforcing expectations for better profitability further out.
• Neutral Sentiment: Zacks Research maintained a Hold rating on Avantor, indicating the updates were not strong enough to trigger a more bullish stance.
• Neutral Sentiment: Consensus full-year EPS expectations remain at $0.79, so the analyst changes are incremental rather than a major reset in outlook.
• Negative Sentiment: Near-term estimates were cut for FY2026 to $0.78 from $0.81, Q2 2026 to $0.19 from $0.20, Q3 2026 to $0.20 from $0.21, and Q1 2027 to $0.19 from $0.21, which may temper enthusiasm around immediate earnings momentum.

Insider Activity at Avantor

In other news, Director Simon Dingemans acquired 25,000 shares of Avantor stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the transaction, the director directly owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gregory T. Lucier acquired 10,000 shares of Avantor stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the transaction, the director owned 60,000 shares of the company’s stock, valued at $499,200. This trade represents a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought a total of 160,000 shares of company stock worth $1,287,950 over the last 90 days. Company insiders own 0.28% of the company’s stock.

Avantor Price Performance

Shares of NYSE:AVTR opened at $8.11 on Friday. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $5.53 billion, a P/E ratio of -10.01, a PEG ratio of 4.56 and a beta of 0.94. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a 50-day moving average price of $7.94 and a 200 day moving average price of $9.87.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The firm’s revenue was up .0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.23 earnings per share. Research analysts predict that Avantor, Inc. will post 0.79 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Royal Bank Of Canada assumed coverage on Avantor in a report on Thursday, May 14th. They set a “sector perform” rating and a $9.00 price target on the stock. UBS Group reissued a “neutral” rating and set a $10.50 price target on shares of Avantor in a report on Thursday, February 12th. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. Wells Fargo & Company lowered their price target on Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Finally, Robert W. Baird set a $11.00 price target on Avantor in a report on Thursday, February 12th. Two investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Avantor currently has a consensus rating of “Hold” and a consensus target price of $10.82.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.